24/7 Patient Assistance: 760-405-8205

David Drosick, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information
  • Education & Training


    West Virginia University

    Medical School


    University of Kentucky



    University of Kentucky


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    TriHealth Bethesda North Hospital

    Languages: English/Spanish

    +1 513-865-1111

    10500 Montgomery Rd

    Cincinnati, OH 45242

    Read More
  • Publications & Memberships

    Dr. David Drosick has contributed to 3 publications.

    TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.

    Yardley, D. A.,Arrowsmith, E. R.,Daniel, B. R.,Eakle, J.,Brufsky, A.,Drosick, D. R.,Kudrik, F.,Bosserman, L. D.,Keaton, M. R.,Goble, S. A.,Bubis, J. A.,Priego, V. M.,P...; Breast Cancer Res. Treat.. 2017 May 17

    See more >>

    Sorafenib Plus Ixabepilone as First-Line Treatment of Metastatic HER2-Negative Breast Cancer: A Sarah Cannon Research Institute Phase I/II Trial.

    Yardley, D. A.,Dickson, N.,Drosick, D.,Earwood, C.,Inhorn, R.,Murphy, P.,Hainsworth, J. D.; Clin. Breast Cancer. 1900 Jan 01.

    See more >>

    Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancer.

    Yardley, D. A.,Hart, L.,Waterhouse, D.,Whorf, R.,Drosick, D. R.,Murphy, P.,Badarinath, S.,Daniel, B. R.,Childs, B. H.,Burris, H.; Breast Cancer Res. Treat.. 2013 Nov 21

    See more >>